At the molecular mechanistic level, we hypothesize that the downregulation of miR-613 observed in AF samples may relieve its inhibitory effect on SNAI2 and CXCR4, thus contributing to the enhanced expression of these genes. This evidence concerns the gene CXCR4 and atrial fibrillation.